InvestSMART

Radiopharm Theranostics Limited (ASX: RAD) - Announcements

Current share price for RAD : $0.011 0.001 (8.33%)+

ASX company news and announcements for Radiopharm Theranostics Limited (RAD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Radiopharm Theranostics Limited (RAD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Radiopharm Theranostics Limited (RAD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Radiopharm Theranostics Limited (RAD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$48 Approval received to expand RAD204 Phase 1 trial 19 Nov 2024 1:04PM $0.027 $0.011 fallen by 59.26%
$48 RAD 301 shows strong imaging potential in pancreatic cancer 18 Nov 2024 10:12AM $0.027 $0.011 fallen by 59.26%
$48 Quarterly Activities/Appendix 4C Cash Flow Report 29 Oct 2024 10:41AM $0.025 $0.011 fallen by 56%
$48 Notice of Annual General Meeting 25 Oct 2024 9:55AM $0.027 $0.011 fallen by 59.26%
$48 Change of Director's Interest Notice - IT 23 Oct 2024 6:01PM $0.028 $0.011 fallen by 60.71%
$48 RAD 202 data presented at 2024 EANM Annual Meeting 23 Oct 2024 8:23AM $0.028 $0.011 fallen by 60.71%
$48 BAMF Health to manufacture & dose for RAD101 Phase 2b trial 21 Oct 2024 9:38AM $0.028 $0.011 fallen by 60.71%
$48 RAD partners with AtomVie to develop B7H3 trial doses 16 Oct 2024 8:24AM $0.027 $0.011 fallen by 58.49%
$48 Initial Director's Interest Notice - ND 3 Oct 2024 9:00AM $0.028 $0.011 fallen by 60.71%
$48 Significant progress with B7-H3 targeting radio-antibody 3 Oct 2024 8:23AM $0.028 $0.011 fallen by 60.71%
$48 RAD to present at JonesResearch Radiopharma Day 2 Oct 2024 10:07AM $0.028 $0.011 fallen by 60.71%
$48 Appointment of Noel Donnelly as Non-Executive Director 2 Oct 2024 9:41AM $0.028 $0.011 fallen by 60.71%
$48 ESG Report 30 Sep 2024 4:42PM $0.028 $0.011 fallen by 60.71%
$48 Corporate Governance Statement and Appendix 4G 30 Sep 2024 4:41PM $0.028 $0.011 fallen by 60.71%
$48 Annual Report 30 Sep 2024 4:27PM $0.028 $0.011 fallen by 60.71%
$48 RAD Launching American Depositary Receipt (ADR) Program 19 Sep 2024 9:59AM $0.035 $0.011 fallen by 68.57%
$48 Change of Director's Interest Notice (x6) 18 Sep 2024 9:17AM $0.030 $0.011 fallen by 63.33%
$48 Becoming a substantial holder (PH) 18 Sep 2024 9:11AM $0.030 $0.011 fallen by 63.33%
$48 Notification regarding unquoted securities - RAD 13 Sep 2024 4:21PM $0.030 $0.011 fallen by 63.33%
$48 Notice Under Section 708A 13 Sep 2024 4:18PM $0.030 $0.011 fallen by 63.33%
$48 Application for quotation of securities - RAD 13 Sep 2024 4:15PM $0.030 $0.011 fallen by 63.33%
$48 Appendix 4E and Preliminary Final Report 30 Aug 2024 9:53AM $0.034 $0.011 fallen by 67.65%
$48 Change in substantial holding 29 Aug 2024 6:44PM $0.034 $0.011 fallen by 67.65%
$48 Application for quotation of securities - RAD 29 Aug 2024 5:56PM $0.034 $0.011 fallen by 67.65%
$48 Placement Options Range of Units and Top 20 Holders 28 Aug 2024 11:41AM $0.033 $0.011 fallen by 66.67%

151 - 175 of 612 results

Page 7 of 25

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.